Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dalakas, M. C.
Right arrow Articles by Jacobowitz, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalakas, M. C.
Right arrow Articles by Jacobowitz, D. M.
Neurology 2001;57:780-784
© 2001 American Academy of Neurology


Articles

Stiff person syndrome

Quantification, specificity, and intrathecal synthesis of GAD65 antibodies

Marinos C. Dalakas, MD;, Mian Li, MD, PhD;, Mavis Fujii, MD; and David M. Jacobowitz, PhD

From the Neuromuscular Diseases Section, National Institute of Neurological Diseases and Stroke, NIH, Bethesda, MD.

Address correspondence and reprint requests to Dr. Marinos C. Dalakas, Neuromuscular Diseases Section, National Institute Neurological Diseases and Stroke, NIH, Building 10, Room 4N248, 10 Center Drive, MSC 1382, Bethesda, MD 20892-1382; e-mail:dalakasm{at}ninds.nih.gov

Objective: — To characterize the specificity of anti-GAD65 antibodies in patients with stiff person syndrome (SPS), quantify antibody titers, and examine antibody production within the CNS.

Methods: — The authors studied 18 patients with SPS and positive serum immunoreactivity to gamma-aminobutyric acid (GABA)-ergic neurons. The reactivity of serum and CSF to purified GAD antigen was examined by Western blots, and the anti-GAD65 antibody titers in serum and CSF were quantified by ELISA and compared with 70 disease controls (49 with other autoimmune disorders and 11 with insulin-dependent diabetes mellitus). The intrathecal synthesis of anti-GAD65 IgG was calculated, and the functional significance of the antibodies was examined by measuring the GABA levels in the CSF.

Results: — The serum and CSF of all selected patients with SPS had high anti-GAD65 titers (from 7.0 to 215 µg/mL in serum and from 92 to 2500 ng/mL in CSF) and immunoreacted strongly with recombinant GAD65 on Western blots and with GABA-ergic neurons on rat cerebellum. Among controls, only the serum of eight patients with insulin-dependent diabetes mellitus had low anti-GAD65 antibody titers (from 200 to 1760 ng/mL) but no reactivity to recombinant GAD65. The CSF showed oligoclonal IgG bands in 10 (67%) of 15 patients and an increased anti-GAD65-specific IgG index in 11 (85%) of 13. The mean level of GABA in the CSF was lower in patients with SPS than in controls.

Conclusions: — In patients with SPS, there is marked intrathecal antibody response against neuronal GAD65 epitopes, indicating a clonal B cell activation in the CNS. Anti-GAD65 antibodies at high titers, when confirmed with immunoblots, are highly specific for SPS and appear to impair GABA synthesis.




This article has been cited by other articles:


Home page
NeurologyHome page
M. C. Dalakas
Invited Article: Inhibition of B cell functions: Implications for neurology
Neurology, June 3, 2008; 70(23): 2252 - 2260.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. R. Gordon, A. Z. Zivotofsky, T. Siman-Tov, N. Gadoth, and M. C. Dalakas
Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies
Neurology, April 3, 2007; 68(14): 1161 - 1161.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K. Ishida, H. Mitoma, Y. Wada, T. Oka, J. Shibahara, Y. Saito, S. Murayama, and H. Mizusawa
Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia
J. Neurol. Neurosurg. Psychiatry, February 1, 2007; 78(2): 190 - 192.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
R. Raju, G. Rakocevic, Z. Chen, G. Hoehn, C. Semino-Mora, W. Shi, R. Olsen, and M. C. Dalakas
Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome
Brain, December 1, 2006; 129(12): 3270 - 3276.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. Hernandez-Echebarria, A. Saiz, A. Ares, J. Tejada, L. Garcia-Tunon, C. Nieves, and F. Graus
Paraneoplastic encephalomyelitis associated with pancreatic tumor and anti-GAD antibodies
Neurology, February 14, 2006; 66(3): 450 - 451.
[Full Text] [PDF]


Home page
J. Immunol.Home page
R. Raju, J. Foote, J. P. Banga, T. R. Hall, C. J. Padoa, M. C. Dalakas, E. Ortqvist, and C. S. Hampe
Analysis of GAD65 Autoantibodies in Stiff-Person Syndrome Patients
J. Immunol., December 1, 2005; 175(11): 7755 - 7762.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Ameli, J. Snow, G. Rakocevic, and M. C. Dalakas
A neuropsychological assessment of phobias in patients with stiff person syndrome
Neurology, June 14, 2005; 64(11): 1961 - 1963.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
L. M. Levy, I. Levy-Reis, M. Fujii, and M. C. Dalakas
Brain {gamma}-Aminobutyric Acid Changes in Stiff-Person Syndrome
Arch Neurol, June 1, 2005; 62(6): 970 - 974.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. B. Murinson, M. Butler, K. Marfurt, S. Gleason, P. De Camilli, and M. Solimena
Markedly elevated GAD antibodies in SPS: Effects of age and illness duration
Neurology, December 14, 2004; 63(11): 2146 - 2148.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
G. Rakocevic, R. Raju, and M. C. Dalakas
Anti-Glutamic Acid Decarboxylase Antibodies in the Serum and Cerebrospinal Fluid of Patients With Stiff-Person Syndrome: Correlation With Clinical Severity
Arch Neurol, June 1, 2004; 61(6): 902 - 904.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Koerner, B. Wieland, W. Richter, and H.-M. Meinck
Stiff-person syndromes: Motor cortex hyperexcitability correlates with anti-GAD autoimmunity
Neurology, April 27, 2004; 62(8): 1357 - 1362.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. M. Burns, H. R. Jones, L. H. Phillips II, T. L. Bugawan, H. A. Erlich, and V. A. Lennon
Clinically disparate stiff-person syndrome with GAD65 autoantibody in a father and daughter
Neurology, November 11, 2003; 61(9): 1291 - 1293.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. Bouw, K. Leendertse, M. A. J. Tijssen, and M. Dzoljic
Stiff Person Syndrome and Anesthesia: Case Report
Anesth. Analg., August 1, 2003; 97(2): 486 - 487.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Wessig, R. Klein, M.F. Schneider, K. V. Toyka, M. Naumann, and C. Sommer
Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome
Neurology, July 22, 2003; 61(2): 195 - 198.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P Henningsen and H-M Meinck
Specific phobia is a frequent non-motor feature in stiff man syndrome
J. Neurol. Neurosurg. Psychiatry, April 1, 2003; 74(4): 462 - 465.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. Sudo, Y. Tajima, A. Matsumoto, C. Solaro, and M. C. Dalakas
High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome
N. Engl. J. Med., May 30, 2002; 346(22): 1747 - 1748.
[Full Text] [PDF]


Home page
NEJMHome page
M. C. Dalakas, M. Fujii, M. Li, B. Lutfi, J. Kyhos, and B. McElroy
High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome
N. Engl. J. Med., December 27, 2001; 345(26): 1870 - 1876.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.